chr3-12503592-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_025265.4(TSEN2):​c.639T>C​(p.Asp213Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0182 in 1,598,752 control chromosomes in the GnomAD database, including 501 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 66 hom., cov: 32)
Exomes 𝑓: 0.017 ( 435 hom. )

Consequence

TSEN2
NM_025265.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.813

Publications

8 publications found
Variant links:
Genes affected
TSEN2 (HGNC:28422): (tRNA splicing endonuclease subunit 2) This gene encodes one of the subunits of the tRNA splicing endonuclease. This endonuclease catalyzes the first step in RNA splicing which is the removal of introns. Mutations in this gene have been associated with pontocerebellar hypoplasia type 2. A pseudogene has been identified on chromosome 4. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2009]
TSEN2 Gene-Disease associations (from GenCC):
  • pontocerebellar hypoplasia type 2B
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • pontocerebellar hypoplasia type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 3-12503592-T-C is Benign according to our data. Variant chr3-12503592-T-C is described in ClinVar as Benign. ClinVar VariationId is 137750.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.813 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0538 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSEN2NM_025265.4 linkc.639T>C p.Asp213Asp synonymous_variant Exon 5 of 12 ENST00000284995.11 NP_079541.1 Q8NCE0-1A0A024R2G3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSEN2ENST00000284995.11 linkc.639T>C p.Asp213Asp synonymous_variant Exon 5 of 12 1 NM_025265.4 ENSP00000284995.6 Q8NCE0-1

Frequencies

GnomAD3 genomes
AF:
0.0246
AC:
3741
AN:
152128
Hom.:
63
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0334
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.0479
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.0370
Gnomad SAS
AF:
0.0600
Gnomad FIN
AF:
0.0106
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0138
Gnomad OTH
AF:
0.0374
GnomAD2 exomes
AF:
0.0247
AC:
5950
AN:
240472
AF XY:
0.0251
show subpopulations
Gnomad AFR exome
AF:
0.0317
Gnomad AMR exome
AF:
0.0360
Gnomad ASJ exome
AF:
0.00430
Gnomad EAS exome
AF:
0.0339
Gnomad FIN exome
AF:
0.00963
Gnomad NFE exome
AF:
0.0144
Gnomad OTH exome
AF:
0.0250
GnomAD4 exome
AF:
0.0175
AC:
25278
AN:
1446506
Hom.:
435
Cov.:
32
AF XY:
0.0182
AC XY:
13035
AN XY:
717518
show subpopulations
African (AFR)
AF:
0.0313
AC:
1037
AN:
33120
American (AMR)
AF:
0.0387
AC:
1699
AN:
43882
Ashkenazi Jewish (ASJ)
AF:
0.00344
AC:
86
AN:
24978
East Asian (EAS)
AF:
0.0436
AC:
1721
AN:
39476
South Asian (SAS)
AF:
0.0554
AC:
4663
AN:
84238
European-Finnish (FIN)
AF:
0.0102
AC:
539
AN:
52816
Middle Eastern (MID)
AF:
0.0125
AC:
71
AN:
5682
European-Non Finnish (NFE)
AF:
0.0129
AC:
14201
AN:
1102608
Other (OTH)
AF:
0.0211
AC:
1261
AN:
59706
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
1478
2956
4434
5912
7390
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
640
1280
1920
2560
3200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0247
AC:
3753
AN:
152246
Hom.:
66
Cov.:
32
AF XY:
0.0261
AC XY:
1940
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.0334
AC:
1386
AN:
41534
American (AMR)
AF:
0.0479
AC:
732
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3470
East Asian (EAS)
AF:
0.0373
AC:
193
AN:
5172
South Asian (SAS)
AF:
0.0594
AC:
287
AN:
4828
European-Finnish (FIN)
AF:
0.0106
AC:
113
AN:
10628
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0138
AC:
937
AN:
68010
Other (OTH)
AF:
0.0412
AC:
87
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
188
375
563
750
938
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0170
Hom.:
26
Bravo
AF:
0.0259
Asia WGS
AF:
0.113
AC:
393
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 04, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Pontoneocerebellar hypoplasia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.85
DANN
Benign
0.36
PhyloP100
-0.81
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3796329; hg19: chr3-12545091; API